Decision-Making Authority. With respect to the responsibilities of the Joint Development Committee, each Party shall have one (1) collective vote in all decisions, and the Parties shall attempt to make decisions by reaching agreement. If the JDC cannot reach agreement within *** of a disputed matter being brought to a vote, either Party may refer the dispute to the Parties’ executives for resolution in accordance with Section 15.1 and the other provisions of Article 15. The JDC has no authority to amend, or to waive compliance with, any provisions of this Agreement.
Appears in 3 contracts
Sources: Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc)
Decision-Making Authority. With respect to the responsibilities of the Joint Development Committee, each Party shall have one (1) collective vote in all decisions, and the Parties shall attempt to make decisions by reaching agreement. If the JDC cannot reach agreement within [*** ] of a disputed matter being brought to a votevote of the JDC, either Party may refer the dispute to the Parties’ executives for resolution in accordance with Section 15.1 and the other provisions of Article 15. The JDC has no authority to amend, or to waive compliance with, any provisions of this Agreement.
Appears in 1 contract
Decision-Making Authority. With respect to the responsibilities of the Joint Development Committee, each Party shall have one (1) collective vote [***] in all decisions, and the Parties shall attempt to make decisions by reaching agreement. If the JDC cannot reach agreement within [*** *] of a disputed matter being brought to a vote, either Party may refer the dispute to the Parties’ executives for resolution in accordance with Section 15.1 and the other provisions of Article 15. The JDC has no authority to amend, or to waive compliance with, any provisions of this Agreement.
Appears in 1 contract
Sources: Phase Ib/Ii Combination Study Agreement (Corvus Pharmaceuticals, Inc.)